PHF6-mediated transcriptional control of NSC via Ephrin receptors is impaired in the intellectual disability syndrome BFLS.

Journal: EMBO reports

Volume: 25

Issue: 3

Year of Publication: 2024

Affiliated Institutions:  Department of Cellular and Molecular Medicine, University of Ottawa, Smyth Road, Ottawa, ON, KH M, Canada. Department of Human Genetics, McGill University, Rue University, Montréal, QC, HA OC, Canada. Regenerative Medicine Program and Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, KH L, Canada. Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, , Australia. Roche Pharma Research and Early Development (pRED), Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland. Department of Medicine, Division of Experimental Medicine, McGill University, Decarie Boulevard, Montréal, QC, HA J, Canada. Department of Human Genetics, McGill University, Rue University, Montréal, QC, HA OC, Canada. hamed.najafabadi@mcgill.ca. Department of Cellular and Molecular Medicine, University of Ottawa, Smyth Road, Ottawa, ON, KH M, Canada. arezu.jahani@uottawa.ca.

Abstract summary 

The plant homeodomain zinc-finger protein, PHF6, is a transcriptional regulator, and PHF6 germline mutations cause the X-linked intellectual disability (XLID) Börjeson-Forssman-Lehmann syndrome (BFLS). The mechanisms by which PHF6 regulates transcription and how its mutations cause BFLS remain poorly characterized. Here, we show genome-wide binding of PHF6 in the developing cortex in the vicinity of genes involved in central nervous system development and neurogenesis. Characterization of BFLS mice harbouring PHF6 patient mutations reveals an increase in embryonic neural stem cell (eNSC) self-renewal and a reduction of neural progenitors. We identify a panel of Ephrin receptors (EphRs) as direct transcriptional targets of PHF6. Mechanistically, we show that PHF6 regulation of EphR is impaired in BFLS mice and in conditional Phf6 knock-out mice. Knockdown of EphR-A phenocopies the PHF6 loss-of-function defects in altering eNSCs, and its forced expression rescues defects of BFLS mice-derived eNSCs. Our data indicate that PHF6 directly promotes Ephrin receptor expression to control eNSC behaviour in the developing brain, and that this pathway is impaired in BFLS.

Authors & Co-authors:  Rasool Burban Sharanek Madrigal Hu Yan Qu Voss Slack Thomas Bonni Picketts Soleimani Najafabadi Jahani-Asl

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Ahmed R, Sarwar S, Hu J, Cardin V, Qiu LR, Zapata G, Vandeleur L, Yan K, Lerch JP, Corbett MA, et al. Transgenic mice with an R342X mutation in Phf6 display clinical features of Borjeson-Forssman-Lehmann Syndrome (BFLS) Hum Mol Genet. 2021;30:575–594. doi: 10.1093/hmg/ddab081.
Authors :  15
Identifiers
Doi : 10.1038/s44319-024-00082-0
SSN : 1469-3178
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
BFLS;Ephrin Receptors;Intellectual Disability;Neural Stem Cells;PHF6
Study Design
Study Approach
Country of Study
Publication Country
England